Find Clinical Trial

Home » Find Clinical Trials » Effects of acute and chronic oral administration of S 44121 versus placebo on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1 – A randomized, parallel-group, international multicentre study including a 8-week double-blind placebo controlled period followed by a 8-week single-blind period – Phase II exploratory study

Effects of acute and chronic oral administration of S 44121 versus placebo on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1 – A randomized, parallel-group, international multicentre study including a 8-week double-blind placebo controlled period followed by a 8-week single-blind period – Phase II exploratory study

← Back

Study Phase	Phase 2

Therapeutic Area	Cardiovascular Diseases

Indication	Catecholaminergic Polymorphic Ventricular Tachycardia

Sponsor	Institut de Recherches Internationales Servier (I.R.I.S)

Active substance/ Medical device	S044121

Active Substance Code	S044121

Protocol Code	CL2-44121-008

EudraCT Code	2011-000579-15

Documents and links

Results summary	READ MORE

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.